A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3-5 years and infants aged 6-35 months.
Expert Rev Vaccines
; 17(3): 257-262, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-29363365
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Viral Vaccines
/
Enterovirus A, Human
/
Enterovirus Infections
/
Antibodies, Neutralizing
Type of study:
Clinical_trials
Limits:
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Expert Rev Vaccines
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2018
Document type:
Article
Country of publication:
United kingdom